JP2016536312A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016536312A5 JP2016536312A5 JP2016527304A JP2016527304A JP2016536312A5 JP 2016536312 A5 JP2016536312 A5 JP 2016536312A5 JP 2016527304 A JP2016527304 A JP 2016527304A JP 2016527304 A JP2016527304 A JP 2016527304A JP 2016536312 A5 JP2016536312 A5 JP 2016536312A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nanoparticle
- cell
- nanoparticle composition
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020028423A JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899080P | 2013-11-01 | 2013-11-01 | |
| US61/899,080 | 2013-11-01 | ||
| US201462040242P | 2014-08-21 | 2014-08-21 | |
| US62/040,242 | 2014-08-21 | ||
| PCT/US2014/063545 WO2015066535A1 (en) | 2013-11-01 | 2014-10-31 | Modular particles for immunotherapy |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020028424A Division JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028423A Division JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016536312A JP2016536312A (ja) | 2016-11-24 |
| JP2016536312A5 true JP2016536312A5 (enExample) | 2017-10-19 |
| JP6845691B2 JP6845691B2 (ja) | 2021-03-24 |
Family
ID=51999513
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016527304A Active JP6845691B2 (ja) | 2013-11-01 | 2014-10-31 | 免疫療法のための調節粒子 |
| JP2020028424A Withdrawn JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028423A Active JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2022043714A Withdrawn JP2022078345A (ja) | 2013-11-01 | 2022-03-18 | 免疫療法のための調節粒子 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020028424A Withdrawn JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028423A Active JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2022043714A Withdrawn JP2022078345A (ja) | 2013-11-01 | 2022-03-18 | 免疫療法のための調節粒子 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9884026B2 (enExample) |
| EP (1) | EP3062779B1 (enExample) |
| JP (4) | JP6845691B2 (enExample) |
| KR (2) | KR20190126452A (enExample) |
| CN (2) | CN105848649B (enExample) |
| AU (4) | AU2014342004B2 (enExample) |
| CA (2) | CA2987519A1 (enExample) |
| ES (1) | ES2982087T3 (enExample) |
| RU (1) | RU2672055C2 (enExample) |
| WO (1) | WO2015066535A1 (enExample) |
| ZA (1) | ZA201602826B (enExample) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2347775T3 (da) | 2005-12-13 | 2020-07-13 | Harvard College | Skabeloner til celletransplantation |
| CN107648668B (zh) | 2010-10-06 | 2021-06-18 | 哈佛学院董事会 | 用于基于材料的细胞疗法的可注射的成孔水凝胶 |
| US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
| EP3939572B1 (en) | 2012-04-12 | 2024-03-27 | Yale University | Vehicles for controlled delivery of different pharmaceutical agents |
| CN104244929B (zh) | 2012-04-16 | 2017-04-05 | 哈佛学院董事会 | 用于调节免疫反应的介孔二氧化硅组合物 |
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| EP3760223A1 (en) | 2013-04-03 | 2021-01-06 | N-Fold Llc | Nanoparticle composition for desensitizing a subject to peanut allergens |
| CN105848649B (zh) | 2013-11-01 | 2019-08-02 | 耶鲁大学 | 用于免疫疗法的模块化粒子 |
| EP3094314B1 (en) * | 2014-01-16 | 2021-06-23 | MUSC Foundation For Research Development | Targeted nanocarriers for the administration of immunosuppressive agents |
| US20170173005A1 (en) | 2014-03-27 | 2017-06-22 | Research Foundation Of The City University Of New York | Method for detecting or treating triple negative breast cancer |
| US10682400B2 (en) | 2014-04-30 | 2020-06-16 | President And Fellows Of Harvard College | Combination vaccine devices and methods of killing cancer cells |
| EP3250250A4 (en) * | 2015-01-30 | 2019-05-22 | President and Fellows of Harvard College | PERITUMORAL AND INTRATUMORAL MATERIALS FOR CANCER THERAPY |
| ES2993458T3 (en) | 2015-03-16 | 2024-12-30 | Pdx Pharmaceuticals Inc | Cross-linked polymer modified nanoparticles |
| JP7094533B2 (ja) | 2015-04-10 | 2022-07-04 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 免疫細胞捕捉デバイスおよびその製造および使用方法 |
| CN107708674A (zh) | 2015-05-22 | 2018-02-16 | 阿菲欧斯公司 | 联合hiv疗法 |
| MX2017015127A (es) * | 2015-05-27 | 2018-06-22 | Univ Northwestern | Particulas modificadas por carbohidratos y formulaciones en particulas para modular una respuesta inmunitaria. |
| CN107708672A (zh) * | 2015-06-15 | 2018-02-16 | 华盛顿大学 | 用于延长血液和淋巴组织中的药物水平的多药脂质纳米颗粒组合物和相关方法 |
| JP6882782B2 (ja) | 2015-08-04 | 2021-06-02 | デューク ユニバーシティ | 遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法 |
| US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
| EP3411475B1 (en) | 2016-02-06 | 2025-08-27 | President and Fellows of Harvard College | Recapitulating the hematopoietic niche to reconstitute immunity |
| WO2017144543A1 (en) * | 2016-02-22 | 2017-08-31 | Onxeo | Combination therapies comprising immuno-oncology agents and belinostat |
| EP3804620B1 (en) * | 2016-03-01 | 2022-02-16 | North Carolina State University | Enhanced cancer immunotherapy by microneedle patch-assisted delivery |
| WO2017210476A1 (en) | 2016-06-01 | 2017-12-07 | Duke University | Nonfouling biosensors |
| CA3029813A1 (en) | 2016-06-13 | 2017-12-21 | Torque Therapeutics, Inc. | Methods and compositions for promoting immune cell function |
| CN115537372A (zh) | 2016-07-13 | 2022-12-30 | 哈佛学院院长等 | 抗原呈递细胞模拟支架及其制备和使用方法 |
| EP3493842A4 (en) | 2016-08-02 | 2020-07-29 | President and Fellows of Harvard College | BIOMATERIALS TO MODULATE IMMUNE RESPONSES |
| JP2020500150A (ja) | 2016-09-23 | 2020-01-09 | デューク ユニバーシティ | 下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド |
| US11648200B2 (en) | 2017-01-12 | 2023-05-16 | Duke University | Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly |
| CA3056802A1 (en) * | 2017-03-16 | 2018-09-20 | Children's Medical Center Corporation | Non-viral, non-cationic nanoparticles and uses thereof |
| CA3056797A1 (en) | 2017-03-16 | 2018-09-20 | Children's Medical Center Corporation | Engineered liposomes as cancer-targeted therapeutics |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| WO2018213320A1 (en) | 2017-05-15 | 2018-11-22 | Duke University | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents |
| WO2019006374A1 (en) | 2017-06-30 | 2019-01-03 | Duke University | ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS |
| KR20210032924A (ko) | 2017-09-05 | 2021-03-25 | 토크 테라퓨틱스, 인코포레이티드 | 치료용 단백질 조성물 및 그의 제조 및 사용 방법 |
| WO2019147954A1 (en) | 2018-01-26 | 2019-08-01 | Duke University | Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same |
| GB201804634D0 (en) * | 2018-03-22 | 2018-05-09 | Aqdot Ltd | Emulsion stabiliser |
| EP3788343B1 (en) | 2018-04-30 | 2024-03-27 | Duke University | Stimuli-responsive peg-like polymer-based drug delivery platform |
| US11517628B2 (en) * | 2018-05-09 | 2022-12-06 | Yale University | Particles for spatiotemporal release of agents |
| US20210275588A1 (en) * | 2018-07-10 | 2021-09-09 | The Regents Of The University Of California | Biomolecule Coated Particles and Films and Uses Thereof |
| KR20210044212A (ko) * | 2018-07-12 | 2021-04-22 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 면역 반응을 조절할 수 있는 금속 함유 제형의 조성물 및 방법 |
| WO2020028806A1 (en) | 2018-08-02 | 2020-02-06 | Duke University | Dual agonist fusion proteins |
| WO2020061129A1 (en) | 2018-09-19 | 2020-03-26 | President And Fellows Of Harvard College | Compositions and methods for labeling and modulation of cells in vitro and in vivo |
| CA3113645A1 (en) * | 2018-09-20 | 2020-03-26 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Targeting moiety-drug grafted immune cell compositions and methods of use |
| WO2020072495A1 (en) | 2018-10-01 | 2020-04-09 | The Board Of Trustees Of The Leland Stanford Junior University | Injectable hydrogels for controlled release of immunomodulatory compounds |
| CA3115677A1 (en) * | 2018-10-19 | 2020-04-23 | University Of Rochester | Immune modulators in combination with radiation treatment for advanced pancreatic cancer |
| RU2706427C1 (ru) * | 2018-12-27 | 2019-11-19 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата |
| WO2020150623A1 (en) * | 2019-01-18 | 2020-07-23 | University Of Georgia Research Foundation, Inc. | Salt nanoparticles and compositions and methods of use thereof |
| US12263252B2 (en) | 2019-06-05 | 2025-04-01 | The Florida International University Board Of Trustees | Biotherapy for viral infections using biopolymer based micro/nanogels |
| US20200383932A1 (en) * | 2019-06-05 | 2020-12-10 | The Florida International University Board Of Trustees | Biotherapy for viral infections using biopolymer based micro/nanogels |
| WO2021011496A1 (en) * | 2019-07-12 | 2021-01-21 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| CA3139714A1 (en) | 2019-07-12 | 2021-01-21 | Wassana Yantasee | Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor |
| US11512314B2 (en) | 2019-07-12 | 2022-11-29 | Duke University | Amphiphilic polynucleotides |
| US20220249389A1 (en) * | 2019-07-12 | 2022-08-11 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| US20220331415A1 (en) * | 2019-09-18 | 2022-10-20 | The Regents Of The University Of California | Immunoactive microparticles and uses thereof |
| RU2712212C1 (ru) * | 2019-10-28 | 2020-01-27 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата |
| BR112022010952A2 (pt) * | 2019-12-05 | 2022-09-06 | West Virginia Univ Board Of Governors On Behalf Of West Virginia Univ | Nanosferas de plga carregadas de proteína |
| WO2021137611A1 (ko) * | 2019-12-30 | 2021-07-08 | (주)테라베스트 | 나노 구조체가 부착된 면역세포 |
| US20230093708A1 (en) * | 2020-03-04 | 2023-03-23 | Duke University | Protein nanoparticle design and application |
| WO2021231942A1 (en) * | 2020-05-15 | 2021-11-18 | The Board Of Trustees Of The Leland Stanford Junior University | Toll-like receptor (tlr) agonist nanoparticles and uses thereof |
| WO2022006011A1 (en) * | 2020-07-01 | 2022-01-06 | Cello Therapeutics, Inc. | Platelet membrane coated nanoparticles and uses thereof |
| CN112451504B (zh) * | 2020-11-09 | 2022-10-18 | 四川大学华西医院 | 一种载EBV-LMP2 mRNA的核-壳纳米粒的制备方法及应用 |
| US11672875B2 (en) | 2021-03-17 | 2023-06-13 | Saint Louis University | Nanoparticle-alginate gels for X-ray imaging of the vasculature |
| US20240180849A1 (en) * | 2021-04-20 | 2024-06-06 | Purdue Research Foundation | Immunofunctional carrier, methods of uses, and composition matters as an antitumor immunotherapy |
| GB2605996B (en) * | 2021-04-21 | 2024-09-25 | Act Therapeutics Ltd | Enhancement of treatment with immunotherapeutic agents |
| WO2022225203A1 (ko) * | 2021-04-23 | 2022-10-27 | 서울대학교산학협력단 | 대식세포의 활성 조절용 조성물 |
| WO2023113545A1 (ko) * | 2021-12-16 | 2023-06-22 | 주식회사 포투가바이오 | αPD-1를 포함하는 수지상 세포 모방 기능성 나노구조체 및 이의 제조방법 |
| WO2023113550A1 (ko) * | 2021-12-16 | 2023-06-22 | 주식회사 포투가바이오 | 수지상세포 모방 기능성 나노구조체 및 이의 제조방법 |
| WO2024128868A1 (ko) * | 2022-12-15 | 2024-06-20 | 주식회사 포투가바이오 | αPD-1를 포함하는 수지상 세포 모방 기능성 나노구조체 및 이의 제조방법 |
| CN117731637A (zh) * | 2023-12-20 | 2024-03-22 | 上海爱莫思生物技术有限公司 | 一种mdp纳米颗粒及其应用 |
| WO2025149619A1 (en) * | 2024-01-12 | 2025-07-17 | Topas Therapeutics Gmbh | Nanoparticles comprising amphiphilic polymers and lipids for the targeted delivery of antigens |
| CN120324344B (zh) * | 2025-04-18 | 2025-10-17 | 广州医科大学附属第一医院横琴医院(横琴粤澳深度合作区中心医院) | 一种肿瘤微环境响应型级联靶向小激活核酸纳米药物的制备方法及其应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5138069A (en) | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| US5210079A (en) | 1988-01-07 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists |
| US5354867A (en) | 1988-12-06 | 1994-10-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| WO1995015746A1 (en) | 1993-12-10 | 1995-06-15 | The School Of Pharmacy | Liposome delivery systems |
| US7411051B2 (en) | 1997-03-07 | 2008-08-12 | Human Genome Sciences, Inc. | Antibodies to HDPPA04 polypeptide |
| IL149820A0 (en) | 2002-05-23 | 2002-11-10 | Curetech Ltd | Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| AU2003281200A1 (en) | 2002-07-03 | 2004-01-23 | Tasuku Honjo | Immunopotentiating compositions |
| US7052694B2 (en) | 2002-07-16 | 2006-05-30 | Mayo Foundation For Medical Education And Research | Dendritic cell potentiation |
| US7985422B2 (en) | 2002-08-05 | 2011-07-26 | Torrent Pharmaceuticals Limited | Dosage form |
| US7785578B2 (en) | 2002-10-11 | 2010-08-31 | Aciont, Inc. | Non-invasive ocular drug delivery |
| CN101899114A (zh) | 2002-12-23 | 2010-12-01 | 惠氏公司 | 抗pd-1抗体及其用途 |
| US20060099203A1 (en) | 2004-11-05 | 2006-05-11 | Pease Larry R | B7-DC binding antibody |
| EP1768692B8 (en) | 2004-07-01 | 2015-06-17 | Yale University | Targeted and high density drug loaded polymeric materials |
| US20070166281A1 (en) | 2004-08-21 | 2007-07-19 | Kosak Kenneth M | Chloroquine coupled antibodies and other proteins with methods for their synthesis |
| CN109485727A (zh) | 2005-05-09 | 2019-03-19 | 小野药品工业株式会社 | 程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法 |
| PL1899364T5 (pl) * | 2005-05-17 | 2024-12-09 | University Of Connecticut | Kompozycje i sposoby immunomodulacji w organizmie |
| EP3130350A1 (en) | 2005-06-08 | 2017-02-15 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway |
| KR101411165B1 (ko) | 2005-07-01 | 2014-06-25 | 메다렉스, 엘.엘.시. | 예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날항체 |
| WO2007005754A2 (en) | 2005-07-01 | 2007-01-11 | Alza Corporation | Liposomal delivery vehicle for hydrophobic drugs |
| DE102005039579B4 (de) | 2005-08-19 | 2022-06-30 | Magforce Ag | Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen |
| US20070243184A1 (en) | 2005-11-08 | 2007-10-18 | Steven Fischkoff | Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy |
| US8658608B2 (en) | 2005-11-23 | 2014-02-25 | Yale University | Modified triple-helix forming oligonucleotides for targeted mutagenesis |
| EP1966765A2 (en) | 2005-12-20 | 2008-09-10 | Philips Intellectual Property & Standards GmbH | Method for movement compensation of image data |
| JP2008053276A (ja) | 2006-08-22 | 2008-03-06 | Nec Electronics Corp | 半導体装置の製造方法 |
| NZ720288A (en) | 2006-12-27 | 2020-02-28 | Harvard College | Compositions and methods for the treatment of infections and tumors |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| AU2008240155B2 (en) * | 2007-04-13 | 2012-09-20 | University Of North Texas Health Science Center At Fort Worth | Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics |
| US20090028857A1 (en) | 2007-07-23 | 2009-01-29 | Cell Genesys, Inc. | Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| EP2177230A4 (en) | 2007-08-09 | 2011-04-27 | Daiichi Sankyo Co Ltd | IMMUNOLIPOSOM AS INDUCTOR OF APOPTOSIS INTO DEATH DOMAIN-CONTAINING RECEPTOR EXPRESSING CELL |
| TW200938224A (en) | 2007-11-30 | 2009-09-16 | Medarex Inc | Anti-B7H4 monoclonal antibody-drug conjugate and methods of use |
| EP2927240A1 (en) | 2008-08-25 | 2015-10-07 | Amplimmune, Inc. | Compositions of pd-1 antagonists and methods of use |
| US8277812B2 (en) * | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
| WO2010059253A2 (en) * | 2008-11-24 | 2010-05-27 | Massachusets Institute Of Technology | Methods and compositions for localized agent delivery |
| WO2010083337A2 (en) | 2009-01-15 | 2010-07-22 | The Regents Of The University Of Califorinia | Composite nanostructures and methods for making and using them |
| CN102596178B (zh) | 2009-10-26 | 2014-12-03 | 石药集团中奇制药技术（石家庄）有限公司 | 具有磺丁基醚环糊精盐内水相的脂质体 |
| US20110262406A1 (en) | 2010-04-21 | 2011-10-27 | Yale University | Compositions and methods for targeted inactivation of hiv cell surface receptors |
| US20110293690A1 (en) | 2010-05-27 | 2011-12-01 | Tyco Healthcare Group Lp | Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof |
| JP2013531043A (ja) | 2010-07-16 | 2013-08-01 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 癌の免疫療法のための方法及び組成物 |
| CA2817250A1 (en) | 2010-11-18 | 2012-05-24 | The General Hospital Corporation | Novel compositions and uses of anti-hypertension agents for cancer therapy |
| BR112013028570A2 (pt) * | 2011-05-09 | 2019-09-24 | Institut Quim De Sarria | nanopartículas poliméricas para administração de fármacos |
| EP3939572B1 (en) | 2012-04-12 | 2024-03-27 | Yale University | Vehicles for controlled delivery of different pharmaceutical agents |
| CN105848649B (zh) | 2013-11-01 | 2019-08-02 | 耶鲁大学 | 用于免疫疗法的模块化粒子 |
-
2014
- 2014-10-31 CN CN201480070407.XA patent/CN105848649B/zh active Active
- 2014-10-31 CA CA2987519A patent/CA2987519A1/en not_active Abandoned
- 2014-10-31 KR KR1020197032420A patent/KR20190126452A/ko not_active Ceased
- 2014-10-31 CN CN201910629569.7A patent/CN110302162A/zh active Pending
- 2014-10-31 JP JP2016527304A patent/JP6845691B2/ja active Active
- 2014-10-31 KR KR1020167014652A patent/KR102460800B1/ko active Active
- 2014-10-31 US US15/034,106 patent/US9884026B2/en active Active
- 2014-10-31 EP EP14805404.2A patent/EP3062779B1/en active Active
- 2014-10-31 RU RU2016121422A patent/RU2672055C2/ru active
- 2014-10-31 CA CA2929277A patent/CA2929277C/en active Active
- 2014-10-31 ES ES14805404T patent/ES2982087T3/es active Active
- 2014-10-31 WO PCT/US2014/063545 patent/WO2015066535A1/en not_active Ceased
- 2014-10-31 AU AU2014342004A patent/AU2014342004B2/en active Active
-
2016
- 2016-04-25 ZA ZA201602826A patent/ZA201602826B/en unknown
-
2017
- 2017-12-07 AU AU2017272274A patent/AU2017272274A1/en not_active Abandoned
-
2018
- 2018-01-03 US US15/860,888 patent/US10751291B2/en active Active
-
2019
- 2019-10-09 AU AU2019246802A patent/AU2019246802B2/en active Active
-
2020
- 2020-02-21 JP JP2020028424A patent/JP2020075940A/ja not_active Withdrawn
- 2020-02-21 JP JP2020028423A patent/JP6929572B2/ja active Active
- 2020-08-06 US US16/986,393 patent/US20210015758A1/en not_active Abandoned
-
2021
- 2021-08-26 AU AU2021221886A patent/AU2021221886A1/en not_active Abandoned
-
2022
- 2022-03-18 JP JP2022043714A patent/JP2022078345A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016536312A5 (enExample) | ||
| RU2016121422A (ru) | Модульные частицы для иммунотерапии | |
| Phuengkham et al. | A designer scaffold with immune nanoconverters for reverting immunosuppression and enhancing immune checkpoint blockade therapy | |
| Ban et al. | Emerging systemic delivery strategies of oncolytic viruses: a key step toward cancer immunotherapy | |
| Fontana et al. | Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy? | |
| Simpson et al. | Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances | |
| Xu et al. | Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12 | |
| JP2019534308A5 (enExample) | ||
| Ramakrishnan et al. | Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer | |
| Luo et al. | Nanocarrier co-formulation for delivery of a TLR7 agonist plus an immunogenic cell death stimulus triggers effective pancreatic cancer chemo-immunotherapy | |
| Zheng et al. | Using chemo-drugs or irradiation to break immune tolerance and facilitate immunotherapy in solid cancer | |
| WO2016004048A3 (en) | Targeted conjugates and particles and formulations thereof | |
| EP2620157A3 (en) | Vaccine nanotechnology | |
| NZ593343A (en) | Combination cancer treatment conprising Abraxane and an inflamatory inhibitor | |
| García et al. | Self-assembled nanomaterials | |
| EP3064220A3 (en) | Compositions and methods for the treatment of infections and tumors | |
| JP2016513953A5 (enExample) | ||
| JP7570134B2 (ja) | 治療用ワクチンとしての使用のためのナノ粒子 | |
| WO2015153805A3 (en) | Targeted polymerized nanoparticles for cancer treatment | |
| Lee et al. | Poly d, l-lactide-co-glycolide (PLGA) nanoparticle-encapsulated honeybee (Apis melifera) venom promotes clearance of Salmonella enterica serovar Typhimurium infection in experimentally challenged pigs through the up-regulation of T helper type 1 specific immune responses | |
| CN106237340B (zh) | 透明质酸纳米颗粒在制备治疗淋巴系统肿瘤的药物的用途 | |
| Phung et al. | Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review | |
| Nikitczuk et al. | PLGA-polymer encapsulating tumor antigen and CpG DNA administered into the tumor microenvironment elicits a systemic antigen-specific IFN-γ response and enhances survival | |
| JP2012506394A5 (enExample) | ||
| Schafer et al. | NK cell exhaustion: bad news for chronic disease? |